Combination therapy for treatment of psychoses
OwnerFranklin Porter Bymaster, Harlan Edgar Shannoninventors
Life of this patent
Estimating the term…
Abstract
The invention provides combination therapy comprising a first component which is a typical antipsychotic or an atypical antipsychotic and a second component which is a muscarinic agonist for the treatment of psychoses and other disorders.
Claims11
A method for treating a patient suffering from or susceptible to psychosis, comprising administering to the patient an effective amount a first component which is a typical antipsychotic or an atypical antipsychotic and an effective amount of a second component which is a muscarinic agonist.
A method of treating a patient suffering or susceptible to Alzheimer's disease, comprising administering to the patient an effective amount a first component which is a typical antipsychotic or an atypical antipsychotic and an effective amount of a second component which is a muscarinic agonist.
A pharmaceutical composition comprising an effective amount a first component which is a typical antipsychotic or an atypical antipsychotic and a second component which is a muscarinic agonist.
The use of a first component which is a typical antipsychotic or an atypical antipsychotic and an effective amount of a second component which is a muscarinic agonist for the manufacture of a medicament for treating psychosis.
The use of a first component which is a typical antipsychotic or an atypical antipsychotic and an effective amount of a second component which is a muscarinic agonist for the manufacture of a medicament for treating Alzheimer's disease.
Dependencies are inferred from the claim text.